0.57
-0.2554(-30.77%)
Currency In USD
Address
219 Terry Ave. N
Seattle, WA 98109
United States of America
Phone
206 378 0400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11
First IPO Date
February 11, 2016
| Name | Title | Pay | Year Born |
| Ms. Pauline Kenny Esq., J.D. | Advisor | 349,716 | 1974 |
| Mr. Keith A. Baker | Chief Financial Officer | 485,746 | 1967 |
| Mr. Craig W. Philips | President & Secretary | 541,671 | 1961 |
| Dr. Thierry Guillaudeux Ph.D. | Chief Scientific Officer | 0 | 1968 |
| Mr. Gary Gentges | Executive Vice President of Corporate Development | 0 | N/A |
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.